Trust Cepheid for your sexual health diagnostics needs. Our advanced solutions ensure accurate, fast, and reliable results for a wide range of sexually transmitted infections (STI) and vaginal infections. 

With years of expertise and cutting-edge technology, Cepheid is dedicated to improving patient outcomes and supporting healthcare providers in delivering the highest standard of care.

Our diagnostic tests are designed to meet the demands of modern healthcare environments, providing rapid and precise detection of infections such as Chlamydia, Gonorrhea, Group B Strep, and multiple vaginal infections. By leveraging molecular diagnostic techniques, we offer unparalleled sensitivity and specificity, ensuring that you can trust the results you receive.

Whether you are a clinician looking to enhance your diagnostic capabilities or a laboratory aiming to improve workflow efficiency, Cepheid's sexual health portfolio offers comprehensive solutions tailored to your needs.

Empower healthcare providers, enhance patient care, and revolutionize your practice with our cutting-edge technology. Explore our full range of tests and discover our unwavering commitment to quality and innovation.

• Accurate Results: Trustworthy diagnostics for confident decisions.
• Fast Turnaround: Get quick results for timely treatment.
• User-Friendly: Easy-to-use systems that streamline workflows.
• Innovative Technology: A leader in molecular diagnostics for superior performance.

Contact Us Today!

Request more information or schedule a demo.

The Xpert Xpress MVP test is designed to detect multiple vaginal infections of symptomatic women within an hour.

• Accurate Diagnosis: Identifies bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis within 60 minutes, including potential co-infections
• On-demand results: Four separate callouts, bacterial vaginosis, Candida group,* C. glabrata/C. krusei, and T. vaginalis from a single sample collection
• CLIA Waived PCR Testing: Simplifies testing with high-standard, CLIA waived diagnostics.

Learn More About Xpert Xpress MVP

This next-generation qualitative, real-time PCR test enables fast and accurate testing for intrapartum detection of Group B Streptococcus during labor and delivery - driving appropriate antibiotic treatment and reducing the risk of neonatal diseases.

• Identify GBS colonization status at the time of labor (intrapartum) of low-risk women at term with unknown GBS status.
• Xpert Xpress GBS test is designed to run in the clinical lab 24 hours a day, 365 days a year.
• Fast and easy-to-interpret results enable adequate Intrapartum Antibiotic Prophylaxis (IAP) delivered to mothers with unknown status.

Learn More -  Xpert Xpress GBS

• Delivers an elegant, simple and streamlined solution for antepartum GBS testing as an alternative to culture.
• Designed for use in the clinical lab allowing users to perform three simple steps while the GeneXpert system does the rest.
• Fast, accurate and easy-to-interpret results enable adequate IAP delivered to mothers at the time of delivery.

More Information on Xpert GBS LB XC

90-minute detection and differentiation of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG).

• On-demand and in-visit results can possibly reduce patient call-backs, overtreatment, undertreatment and patients lost to follow-up
• Patient collected specimens can create operational efficiencies
• Same patient sample can be utilized for all tests

Additional Information on Xpert CT/NG

Fast and accurate diagnosis of Trichomoniasis in 90 minutes or less.

• The Xpert TV test provides accurate, on-demand PCR results when you need them.
• On-demand and in-visit results can possibly reduce patient call-backs,
  overtreatment, undertreatment and patients lost to follow-up
• Patient collected specimens may possibly create operational efficiencies and improve patient satisfaction

Learn More Today

Cepheid's Xpert Xpress MVP test, performed on the GeneXpert and GeneXpert Xpress systems, delivers an accurate, simple, and flexible solution for uncomplicating the diagnosis of vaginitis. It delivers single-test confidence, aiding clinicians in diagnosing three distinct conditions from one sample. 

Watch to Learn More

US-IVD. In Vitro Diagnostic Medical Device. May not be available in all countries.

* Target includes C. albicans, C. tropicalis, C. parapsilosis, and C. dubliniensis.